Zhenyu Liang Selected Research

Toluene 2,4-Diisocyanate (Toluene Diisocyanate)

10/2022	Corrigendum to "Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma" [Allergol Int 71(2022):73-82].
1/2022	Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma.
7/2020	Toll-like Receptor 4 Deficiency Aggravates Airway Hyperresponsiveness and Inflammation by Impairing Neutrophil Apoptosis in a Toluene Diisocyanate-Induced Murine Asthma Model.
7/2019	Corrigendum to "Transient Receptor Potential Ion Channels Mediate Adherens Junctions Dysfunction in a Toluene Diisocyanate-Induced Murine Asthma Model".
1/2019	Transient Receptor Potential Ion Channels Mediate Adherens Junctions Dysfunction in a Toluene Diisocyanate-Induced Murine Asthma Model.
1/2019	IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model.
6/2013	Mechanism of E-cadherin redistribution in bronchial airway epithelial cells in a TDI-induced asthma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenyu Liang Research Topics

Disease

18	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 01/2011
15	Asthma (Bronchial Asthma) 11/2022 - 01/2011
12	Inflammation (Inflammations) 01/2022 - 06/2013
4	Respiratory Hypersensitivity 01/2022 - 01/2019
3	Disease Progression 05/2024 - 01/2021
3	Infections 04/2022 - 01/2021
2	COVID-19 05/2024 - 01/2023
2	Pneumonia (Pneumonitis) 01/2023 - 01/2021
2	Metaplasia 01/2022 - 01/2019
2	Adenocarcinoma of Lung 01/2020 - 05/2016
2	Hyperplasia 09/2019 - 01/2012
2	Occupational Asthma 01/2019 - 06/2013
2	Lung Neoplasms (Lung Cancer) 05/2016 - 12/2015
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2023
1	Hepatomegaly 12/2023
1	Shock 12/2023
1	Septic Shock (Toxic Shock Syndrome) 12/2023
1	Sepsis (Septicemia) 12/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Emphysema 01/2022
1	Chronic Bronchitis 07/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Bronchopulmonary Dysplasia 01/2021
1	Bronchiolitis 01/2021
1	Hyperoxia 01/2021
1	Newborn Respiratory Distress Syndrome 01/2021
1	Lung Injury 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020

Drug/Important Bio-Agent (IBA)

7	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 10/2022 - 06/2013
6	AutoantibodiesIBA 01/2022 - 01/2019
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
5	CollagenIBA 01/2022 - 01/2012
5	Immunoglobulin G (IgG)IBA 01/2021 - 01/2019
4	GoldIBA 03/2023 - 01/2011
4	Immunoglobulin M (IgM)IBA 01/2021 - 01/2019
3	SteroidsIBA 10/2022 - 01/2019
3	Particulate MatterIBA 04/2022 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2011
3	AntibodiesIBA 08/2020 - 09/2019
3	AutoantigensIBA 08/2020 - 09/2019
3	HMGB1 Protein (HMG1)IBA 07/2014 - 01/2011
2	HydrogenIBA 11/2022 - 09/2019
2	OvalbuminIBA 11/2022 - 09/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 01/2022 - 09/2019
2	InterleukinsIBA 01/2021 - 01/2019
2	Butyrates (Butyrate)IBA 11/2020 - 01/2020
2	16S Ribosomal RNAIBA 11/2020 - 01/2020
2	AntigensIBA 08/2020 - 01/2019
2	Aggrecans (Aggrecan)IBA 06/2020 - 01/2019
2	Interleukin-4 (Interleukin 4)IBA 09/2019 - 03/2017
2	Ion Channels (Ion Channel)IBA 07/2019 - 01/2019
2	Cadherins (E-Cadherin)IBA 01/2019 - 06/2013
2	CytokinesIBA 03/2017 - 06/2016
1	Ritonavir (Norvir)FDA Link 05/2024
1	TabletsIBA 05/2024
1	Type III Secretion SystemsIBA 04/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2023
1	Capsules (Microcapsules)IBA 01/2023
1	prednylidene (Pred)IBA 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	indoleacetic acid (indole acetic acid)IBA 01/2022
1	ProteomeIBA 01/2022
1	Methacholine Chloride (Methacholine)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	MacrolidesIBA 01/2022
1	Biological FactorsIBA 07/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	JNK Mitogen-Activated Protein KinasesIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	Monocyte Chemoattractant ProteinsIBA 01/2021
1	Semaphorin-3AIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Air Pollutants (Pollutants, Air)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	PalmitatesIBA 11/2020
1	HomocysteineIBA 11/2020
1	Iodide Peroxidase (Deiodinase)IBA 08/2020
1	Histidine-tRNA LigaseIBA 08/2020
1	Peroxidase (Myeloperoxidase)IBA 08/2020
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2020
1	ribosomal protein P0IBA 08/2020
1	U1 Small Nuclear RibonucleoproteinIBA 08/2020
1	venetoclaxIBA 07/2020
1	Toll-Like Receptor 4IBA 07/2020
1	ABT-737IBA 07/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2020
1	Amyloid beta-PeptidesIBA 06/2020
1	PlatinumIBA 01/2020

Therapy/Procedure

3	Therapeutics 03/2023 - 01/2022
2	Artificial Respiration (Mechanical Ventilation) 12/2023 - 01/2021
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 08/2017 - 01/2017
1	Resuscitation 12/2023